Viewing Study NCT06200233


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT06200233
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-09
First Post: 2023-12-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module